Treatment of severe neurological deficits with IgG depletion through immunoadsorption in patients with Escherichia coli O104:H4-associated haemolytic uraemic syndrome: a prospective trial-Reference-Cited by-同舟云学术

Treatment of severe neurological deficits with IgG depletion through immunoadsorption in patients with Escherichia coli O104:H4-associated haemolytic uraemic syndrome: a prospective trial

Published:2011-09 Issue:9797 Volume:378 Page:1166-1173
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Greinacher Andreas,Friesecke Sigrun,Abel Peter,Dressel Alexander,Stracke Sylvia,Fiene Michael,Ernst Friedlinde,Selleng Kathleen,Weissenborn Karin,Schmidt Bernhard MW,Schiffer Mario,Felix Stephan B,Lerch Markus M,Kielstein Jan T,Mayerle Julia

Publisher

Elsevier BV

Subject

General Medicine

Reference32 articles.

1. Epidemic profile of Shiga-toxin-producing Escherichia coli O104:H4 outbreak in Germany—preliminary report;Frank;N Engl J Med,2011

2. CNS manifestations of the hemolytic-uremic syndrome. Relationship to metabolic alterations and prognosis;Bale;Am J Dis Child,1980

3. Risk factors for the central nervous system manifestations of gastroenteritis-associated hemolytic-uremic syndrome;Cimolai;Pediatrics,1992

4. Thrombotic microangiopathies;Moake;N Engl J Med,2002

5. A classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disorders;Besbas;Kidney Int,2006

Cited by 122 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SHIGA TOXIN-ASSOCIATED HEMOLYTIC UREMIC SYNDROME WITH SEVERE NEUROLOGIC MANIFESTATIONS RESULTING IN MULTI-ORGAN FAILURE AND DEATH;CHEST;2023-10

2. Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Ninth Special Issue;Journal of Clinical Apheresis;2023-04

3. Severe Neurological Involvement in an Adult with Shiga Toxin-Producing Escherichia coli-Hemolytic Uremic Syndrome Treated with Eculizumab;Case Reports in Nephrology and Dialysis;2023-01-27

4. Postinfectious Hemolytic Uremic Syndrome;Pediatric Kidney Disease;2023

5. Hemolytic-Uremic Syndrome in Children;Pediatric Clinics of North America;2022-12